Literature DB >> 7368279

HLA-DR typing by radioimmunoassay.

R Tosi, N Tanigaki, D Centis, P L Rossi, G Alfano, G B Ferrara, D Pressman.   

Abstract

A radioimmunoassay procedure is described by which peripheral blood lymphocytes can be typed for HLA-DR specificities. The major advantages of this method are the following: simple and reproducible procedure, no need for B lymphocyte separation, no need for optimal viability, and no need for preabsorption of antisera with platelets. This method will find an application in the genetic and biochemical analysis of the HLA complex, and in the clinical tests of Ia antigens for diagnostic or prognostic purposes and in retrospective transplant studies.

Mesh:

Substances:

Year:  1980        PMID: 7368279     DOI: 10.1097/00007890-198004000-00008

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

1.  Generation of rabbit antipeptide antibodies to HLA-class II antigens by the use of synthetic peptides.

Authors:  A Chersi; M C Morganti; F Chillemi; R Houghten; C Cenciarelli
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

2.  Radioimmunoassay typing gives a more precise definition of the HLA association of type 1 (insulin-dependent) diabetes.

Authors:  R Tosi; M Vela; D Adorno; A Longo; F Papola; D Maccarone; D Centis; N Tanigaki; M P Raponi; A Candela
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

3.  Arg74 in HLA-DRB1 and DRB3 controls a DR3-related epitope.

Authors:  R Sorrentino; C Iannicola; S Costanzi; G Ratti; C Hurley; R Tosi; N Tanigaki
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

4.  Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta.

Authors:  A Dolei; M R Capobianchi; F Ameglio
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

5.  Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci.

Authors:  F Ameglio; M R Capobianchi; A Dolei; R Tosi
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

6.  Human Ia molecules carrying DC1 or BR4X7 determinants are not homologous to murine I-E molecules.

Authors:  R Tosi; N Tanigaki; R Sorrentino; P van Mourik; P Ivanyi
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

7.  Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line.

Authors:  N Tanigaki; R Tosi; R J Duquesnoy; G B Ferrara
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

8.  Serological and immunochemical analysis of the products of a single HLA DR-alpha and DR-beta chain gene expressed in a mouse cell line after DNA-mediated cotransformation reveals that the beta chain carries a known supertypic specificity.

Authors:  J Gorski; R Tosi; M Strubin; C Rabourdin-Combe; B Mach
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.